scispace - formally typeset
L

Leif Bertilsson

Researcher at Karolinska University Hospital

Publications -  321
Citations -  24620

Leif Bertilsson is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Debrisoquine & Debrisoquin. The author has an hindex of 87, co-authored 321 publications receiving 23933 citations. Previous affiliations of Leif Bertilsson include Astra & University of Oulu.

Papers
More filters
Journal ArticleDOI

Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.

TL;DR: Low plasma cholesterol, high CYP3A activity, and high plasma efavirenz concentrations as significant predictors of early ef Cavirenz-based cART-induced vitamin D deficiency are indicated.
Journal ArticleDOI

Fluconazole-induced intoxication with phenytoin in a patient with ultra-high activity of CYP2C9.

TL;DR: The finding of an ultrarapid metabolism of losartan and phenytoin may apply to other CYP2C9 substrates, where inhibition of CYP 2C9 may cause severe adverse drug reactions.
Journal ArticleDOI

Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients

TL;DR: The association between CYP3A4 activity and inflammatory biomarkers suggest that the activity of CYP2A4 is reduced by inflammation in HD patients, and further studies are needed to confirm this finding.
Journal ArticleDOI

Long-Term Effect of Rifampicin-Based Anti-TB Regimen Coadministration on the Pharmacokinetic Parameters of Efavirenz and 8-Hydroxy-Efavirenz in Ethiopian Patients

TL;DR: Higher exposure to 8‐OH‐EFV during simultaneous coadministration of EFV and RIF‐based anti‐TB regimens, which may be associated with neurotoxicity, is called for, particularly in female patients and CYP2B6*6 carriers.
Journal ArticleDOI

Nortriptyline formation after single oral and intramuscular doses of amitriptyline.

TL;DR: The area under the plasma concentration‐time curve (AUC) for nortriptyline formed was calculated and there was no difference between the AUCs (corrected for dose) after the two routes of administration.